Zentek Ltd.
TSXV ZEN.V
Zentek Ltd. Net Cash Used For Investing Activities for the year ending March 31, 2024: USD 1.39 M
-
Zentek Ltd. Net Cash Used For Investing Activities for the year ending March 31, 2023 was USD -1.71 M, a 70.58% change year over year.
-
Zentek Ltd. Net Cash Used For Investing Activities for the year ending March 31, 2022 was USD -5.80 M, a -490.58% change year over year.
-
Zentek Ltd. Net Cash Used For Investing Activities for the year ending March 31, 2021 was USD -981.45 K.
| Date | Net Cash Used For Investing Activities | Net Cash Used Provided By Financing Activities | Dividends Paid | Capital Expenditure |
|---|
Don’t Miss A Beat
| CEO | Mr. Gregory Fenton C.F.A. |
| IPO Date | Dec. 23, 2010 |
| Location | Canada |
| Headquarters | 1205 Amber Drive |
| Employees | 24 |
| Sector | Materials |
| Industries | |
Zentek Ltd. engages in the research and development of graphene and related nanomaterials in Canada. It owns 100% interest in the Albany Graphite project located in Northern Ontario, Canada. The company develops graphene-based antimicrobial coating under the ZenGUARD brand, surgical masks, HVAC filters, personal protective equipment, rapid detection point of care diagnostics tests, and pharmaceutical products based on graphene-based compound. In addition, it develops synthesize graphene, graphene oxide, and graphene quantum dots for applications of graphene. The company was formerly known as ZEN Graphene Solutions Ltd. and changed its name to Zentek Ltd. in October 2021. Zentek Ltd. was incorporated in 2008 and is headquartered in Thunder Bay, Canada.
Past 5 years
StockViz Staff
February 6, 2025
Any question? Send us an email